Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Passeo-35 Xeo Peripheral Dilatation Catheter

K-Number: K222065 · 2023-02-16

Decision Date2023-02-16
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Passeo-35 Xeo Peripheral Dilatation Catheter is a medical device manufactured by Biotronik, Inc.. It received FDA 510(k) clearance on 2023-02-16 under approval number K222065. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Passeo-35 Xeo Peripheral Dilatation Catheter?

Passeo-35 Xeo Peripheral Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2023-02-16. It is manufactured by Biotronik, Inc.. The 510(k) number is K222065.

When was Passeo-35 Xeo Peripheral Dilatation Catheter approved by the FDA?

Passeo-35 Xeo Peripheral Dilatation Catheter received FDA 510(k) clearance on 2023-02-16, under approval number K222065.

What company makes Passeo-35 Xeo Peripheral Dilatation Catheter?

Passeo-35 Xeo Peripheral Dilatation Catheter is manufactured by Biotronik, Inc..

What is the FDA product code for Passeo-35 Xeo Peripheral Dilatation Catheter?

The FDA product code for Passeo-35 Xeo Peripheral Dilatation Catheter is LIT.

Related Clinical Trials

Other Devices by Biotronik, Inc.

View all 29 devices →

Related Devices (Code: LIT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.